 | • レポートコード：MRC2-11QY13784 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はピオグリタゾンHCLのグローバル市場について調査・分析したレポートです。種類別（15mg、30mg、45mg）市場規模、用途別（工業、医薬品、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ピオグリタゾンHCLの競争状況、市場シェア ・世界のピオグリタゾンHCL市場：種類別市場規模 2015年-2020年（15mg、30mg、45mg） ・世界のピオグリタゾンHCL市場：種類別市場規模予測 2021年-2026年（15mg、30mg、45mg） ・世界のピオグリタゾンHCL市場：用途別市場規模 2015年-2020年（工業、医薬品、その他） ・世界のピオグリタゾンHCL市場：用途別市場規模予測 2021年-2026年（工業、医薬品、その他） ・北米のピオグリタゾンHCL市場分析：米国、カナダ ・ヨーロッパのピオグリタゾンHCL市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのピオグリタゾンHCL市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のピオグリタゾンHCL市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのピオグリタゾンHCL市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BOC Sciences、London Drugs、Abhilasha Pharma Pvt Ltd、Tocris、ChemSpider、Rxlist、Beijing Taiyang、Sigma Aldrich、Hubei Jusheng Technology、Xiamen Hisunny Chemical、Cangzhou Senary Chemical Science-tech、SHANDONG JIULONG HISINCE PHARMACEUTICAL、Hubei YuanCheng SaiChuang Technology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pioglitazone HCL Market
The global Pioglitazone HCL market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pioglitazone HCL Scope and Market Size
Pioglitazone HCL market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pioglitazone HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pioglitazone HCL market is segmented into
15 mg
30 mg
45 mg
Segment by Application, the Pioglitazone HCL market is segmented into
Industrial
Pharmaceuticals
Other
Regional and Country-level Analysis
The Pioglitazone HCL market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pioglitazone HCL market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pioglitazone HCL Market Share Analysis
Pioglitazone HCL market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pioglitazone HCL business, the date to enter into the Pioglitazone HCL market, Pioglitazone HCL product introduction, recent developments, etc.
The major vendors covered:
BOC Sciences
London Drugs
Abhilasha Pharma Pvt Ltd
Tocris
ChemSpider
Rxlist
Beijing Taiyang
Sigma Aldrich
Hubei Jusheng Technology
Xiamen Hisunny Chemical
Cangzhou Senary Chemical Science-tech
SHANDONG JIULONG HISINCE PHARMACEUTICAL
Hubei YuanCheng SaiChuang Technology
1 Study Coverage
1.1 Pioglitazone HCL Product Introduction
1.2 Market Segments
1.3 Key Pioglitazone HCL Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pioglitazone HCL Market Size Growth Rate by Type
1.4.2 15 mg
1.4.3 30 mg
1.4.4 45 mg
1.5 Market by Application
1.5.1 Global Pioglitazone HCL Market Size Growth Rate by Application
1.5.2 Industrial
1.5.3 Pharmaceuticals
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pioglitazone HCL Market Size, Estimates and Forecasts
2.1.1 Global Pioglitazone HCL Revenue 2015-2026
2.1.2 Global Pioglitazone HCL Sales 2015-2026
2.2 Global Pioglitazone HCL, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pioglitazone HCL Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pioglitazone HCL Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pioglitazone HCL Competitor Landscape by Players
3.1 Pioglitazone HCL Sales by Manufacturers
3.1.1 Pioglitazone HCL Sales by Manufacturers (2015-2020)
3.1.2 Pioglitazone HCL Sales Market Share by Manufacturers (2015-2020)
3.2 Pioglitazone HCL Revenue by Manufacturers
3.2.1 Pioglitazone HCL Revenue by Manufacturers (2015-2020)
3.2.2 Pioglitazone HCL Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pioglitazone HCL Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pioglitazone HCL Revenue in 2019
3.2.5 Global Pioglitazone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pioglitazone HCL Price by Manufacturers
3.4 Pioglitazone HCL Manufacturing Base Distribution, Product Types
3.4.1 Pioglitazone HCL Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pioglitazone HCL Product Type
3.4.3 Date of International Manufacturers Enter into Pioglitazone HCL Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pioglitazone HCL Market Size by Type (2015-2020)
4.1.1 Global Pioglitazone HCL Sales by Type (2015-2020)
4.1.2 Global Pioglitazone HCL Revenue by Type (2015-2020)
4.1.3 Pioglitazone HCL Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pioglitazone HCL Market Size Forecast by Type (2021-2026)
4.2.1 Global Pioglitazone HCL Sales Forecast by Type (2021-2026)
4.2.2 Global Pioglitazone HCL Revenue Forecast by Type (2021-2026)
4.2.3 Pioglitazone HCL Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pioglitazone HCL Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pioglitazone HCL Market Size by Application (2015-2020)
5.1.1 Global Pioglitazone HCL Sales by Application (2015-2020)
5.1.2 Global Pioglitazone HCL Revenue by Application (2015-2020)
5.1.3 Pioglitazone HCL Price by Application (2015-2020)
5.2 Pioglitazone HCL Market Size Forecast by Application (2021-2026)
5.2.1 Global Pioglitazone HCL Sales Forecast by Application (2021-2026)
5.2.2 Global Pioglitazone HCL Revenue Forecast by Application (2021-2026)
5.2.3 Global Pioglitazone HCL Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pioglitazone HCL by Country
6.1.1 North America Pioglitazone HCL Sales by Country
6.1.2 North America Pioglitazone HCL Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pioglitazone HCL Market Facts & Figures by Type
6.3 North America Pioglitazone HCL Market Facts & Figures by Application
7 Europe
7.1 Europe Pioglitazone HCL by Country
7.1.1 Europe Pioglitazone HCL Sales by Country
7.1.2 Europe Pioglitazone HCL Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pioglitazone HCL Market Facts & Figures by Type
7.3 Europe Pioglitazone HCL Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pioglitazone HCL by Region
8.1.1 Asia Pacific Pioglitazone HCL Sales by Region
8.1.2 Asia Pacific Pioglitazone HCL Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pioglitazone HCL Market Facts & Figures by Type
8.3 Asia Pacific Pioglitazone HCL Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pioglitazone HCL by Country
9.1.1 Latin America Pioglitazone HCL Sales by Country
9.1.2 Latin America Pioglitazone HCL Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pioglitazone HCL Market Facts & Figures by Type
9.3 Central & South America Pioglitazone HCL Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pioglitazone HCL by Country
10.1.1 Middle East and Africa Pioglitazone HCL Sales by Country
10.1.2 Middle East and Africa Pioglitazone HCL Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pioglitazone HCL Market Facts & Figures by Type
10.3 Middle East and Africa Pioglitazone HCL Market Facts & Figures by Application
11 Company Profiles
11.1 BOC Sciences
11.1.1 BOC Sciences Corporation Information
11.1.2 BOC Sciences Description and Business Overview
11.1.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BOC Sciences Pioglitazone HCL Products Offered
11.1.5 BOC Sciences Related Developments
11.2 London Drugs
11.2.1 London Drugs Corporation Information
11.2.2 London Drugs Description and Business Overview
11.2.3 London Drugs Sales, Revenue and Gross Margin (2015-2020)
11.2.4 London Drugs Pioglitazone HCL Products Offered
11.2.5 London Drugs Related Developments
11.3 Abhilasha Pharma Pvt Ltd
11.3.1 Abhilasha Pharma Pvt Ltd Corporation Information
11.3.2 Abhilasha Pharma Pvt Ltd Description and Business Overview
11.3.3 Abhilasha Pharma Pvt Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abhilasha Pharma Pvt Ltd Pioglitazone HCL Products Offered
11.3.5 Abhilasha Pharma Pvt Ltd Related Developments
11.4 Tocris
11.4.1 Tocris Corporation Information
11.4.2 Tocris Description and Business Overview
11.4.3 Tocris Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tocris Pioglitazone HCL Products Offered
11.4.5 Tocris Related Developments
11.5 ChemSpider
11.5.1 ChemSpider Corporation Information
11.5.2 ChemSpider Description and Business Overview
11.5.3 ChemSpider Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ChemSpider Pioglitazone HCL Products Offered
11.5.5 ChemSpider Related Developments
11.6 Rxlist
11.6.1 Rxlist Corporation Information
11.6.2 Rxlist Description and Business Overview
11.6.3 Rxlist Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Rxlist Pioglitazone HCL Products Offered
11.6.5 Rxlist Related Developments
11.7 Beijing Taiyang
11.7.1 Beijing Taiyang Corporation Information
11.7.2 Beijing Taiyang Description and Business Overview
11.7.3 Beijing Taiyang Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Beijing Taiyang Pioglitazone HCL Products Offered
11.7.5 Beijing Taiyang Related Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Corporation Information
11.8.2 Sigma Aldrich Description and Business Overview
11.8.3 Sigma Aldrich Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sigma Aldrich Pioglitazone HCL Products Offered
11.8.5 Sigma Aldrich Related Developments
11.9 Hubei Jusheng Technology
11.9.1 Hubei Jusheng Technology Corporation Information
11.9.2 Hubei Jusheng Technology Description and Business Overview
11.9.3 Hubei Jusheng Technology Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hubei Jusheng Technology Pioglitazone HCL Products Offered
11.9.5 Hubei Jusheng Technology Related Developments
11.10 Xiamen Hisunny Chemical
11.10.1 Xiamen Hisunny Chemical Corporation Information
11.10.2 Xiamen Hisunny Chemical Description and Business Overview
11.10.3 Xiamen Hisunny Chemical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Xiamen Hisunny Chemical Pioglitazone HCL Products Offered
11.10.5 Xiamen Hisunny Chemical Related Developments
11.1 BOC Sciences
11.1.1 BOC Sciences Corporation Information
11.1.2 BOC Sciences Description and Business Overview
11.1.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
11.1.4 BOC Sciences Pioglitazone HCL Products Offered
11.1.5 BOC Sciences Related Developments
11.12 SHANDONG JIULONG HISINCE PHARMACEUTICAL
11.12.1 SHANDONG JIULONG HISINCE PHARMACEUTICAL Corporation Information
11.12.2 SHANDONG JIULONG HISINCE PHARMACEUTICAL Description and Business Overview
11.12.3 SHANDONG JIULONG HISINCE PHARMACEUTICAL Sales, Revenue and Gross Margin (2015-2020)
11.12.4 SHANDONG JIULONG HISINCE PHARMACEUTICAL Products Offered
11.12.5 SHANDONG JIULONG HISINCE PHARMACEUTICAL Related Developments
11.13 Hubei YuanCheng SaiChuang Technology
11.13.1 Hubei YuanCheng SaiChuang Technology Corporation Information
11.13.2 Hubei YuanCheng SaiChuang Technology Description and Business Overview
11.13.3 Hubei YuanCheng SaiChuang Technology Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hubei YuanCheng SaiChuang Technology Products Offered
11.13.5 Hubei YuanCheng SaiChuang Technology Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pioglitazone HCL Market Estimates and Projections by Region
12.1.1 Global Pioglitazone HCL Sales Forecast by Regions 2021-2026
12.1.2 Global Pioglitazone HCL Revenue Forecast by Regions 2021-2026
12.2 North America Pioglitazone HCL Market Size Forecast (2021-2026)
12.2.1 North America: Pioglitazone HCL Sales Forecast (2021-2026)
12.2.2 North America: Pioglitazone HCL Revenue Forecast (2021-2026)
12.2.3 North America: Pioglitazone HCL Market Size Forecast by Country (2021-2026)
12.3 Europe Pioglitazone HCL Market Size Forecast (2021-2026)
12.3.1 Europe: Pioglitazone HCL Sales Forecast (2021-2026)
12.3.2 Europe: Pioglitazone HCL Revenue Forecast (2021-2026)
12.3.3 Europe: Pioglitazone HCL Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pioglitazone HCL Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pioglitazone HCL Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pioglitazone HCL Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pioglitazone HCL Market Size Forecast by Region (2021-2026)
12.5 Latin America Pioglitazone HCL Market Size Forecast (2021-2026)
12.5.1 Latin America: Pioglitazone HCL Sales Forecast (2021-2026)
12.5.2 Latin America: Pioglitazone HCL Revenue Forecast (2021-2026)
12.5.3 Latin America: Pioglitazone HCL Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pioglitazone HCL Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pioglitazone HCL Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pioglitazone HCL Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pioglitazone HCL Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pioglitazone HCL Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pioglitazone HCL Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pioglitazone HCL Market Segments
Table 2. Ranking of Global Top Pioglitazone HCL Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pioglitazone HCL Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of 15 mg
Table 5. Major Manufacturers of 30 mg
Table 6. Major Manufacturers of 45 mg
Table 7. Global Pioglitazone HCL Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Pioglitazone HCL Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Pioglitazone HCL Sales by Regions 2015-2020 (K MT)
Table 10. Global Pioglitazone HCL Sales Market Share by Regions (2015-2020)
Table 11. Global Pioglitazone HCL Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pioglitazone HCL Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Pioglitazone HCL Sales Share by Manufacturers (2015-2020)
Table 14. Global Pioglitazone HCL Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pioglitazone HCL by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pioglitazone HCL as of 2019)
Table 16. Pioglitazone HCL Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pioglitazone HCL Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pioglitazone HCL Price (2015-2020) (USD/MT)
Table 19. Pioglitazone HCL Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pioglitazone HCL Product Type
Table 21. Date of International Manufacturers Enter into Pioglitazone HCL Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 24. Global Pioglitazone HCL Sales Share by Type (2015-2020)
Table 25. Global Pioglitazone HCL Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pioglitazone HCL Revenue Share by Type (2015-2020)
Table 27. Pioglitazone HCL Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 29. Global Pioglitazone HCL Sales Share by Application (2015-2020)
Table 30. North America Pioglitazone HCL Sales by Country (2015-2020) (K MT)
Table 31. North America Pioglitazone HCL Sales Market Share by Country (2015-2020)
Table 32. North America Pioglitazone HCL Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Pioglitazone HCL Revenue Market Share by Country (2015-2020)
Table 34. North America Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 35. North America Pioglitazone HCL Sales Market Share by Type (2015-2020)
Table 36. North America Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 37. North America Pioglitazone HCL Sales Market Share by Application (2015-2020)
Table 38. Europe Pioglitazone HCL Sales by Country (2015-2020) (K MT)
Table 39. Europe Pioglitazone HCL Sales Market Share by Country (2015-2020)
Table 40. Europe Pioglitazone HCL Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Pioglitazone HCL Revenue Market Share by Country (2015-2020)
Table 42. Europe Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 43. Europe Pioglitazone HCL Sales Market Share by Type (2015-2020)
Table 44. Europe Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 45. Europe Pioglitazone HCL Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Pioglitazone HCL Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Pioglitazone HCL Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Pioglitazone HCL Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Pioglitazone HCL Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Pioglitazone HCL Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Pioglitazone HCL Sales Market Share by Application (2015-2020)
Table 54. Latin America Pioglitazone HCL Sales by Country (2015-2020) (K MT)
Table 55. Latin America Pioglitazone HCL Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Pioglitazone HCL Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Pioglitazone HCL Revenue Market Share by Country (2015-2020)
Table 58. Latin America Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 59. Latin America Pioglitazone HCL Sales Market Share by Type (2015-2020)
Table 60. Latin America Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 61. Latin America Pioglitazone HCL Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Pioglitazone HCL Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Pioglitazone HCL Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Pioglitazone HCL Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Pioglitazone HCL Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pioglitazone HCL Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Pioglitazone HCL Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Pioglitazone HCL Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Pioglitazone HCL Sales Market Share by Application (2015-2020)
Table 70. BOC Sciences Corporation Information
Table 71. BOC Sciences Description and Major Businesses
Table 72. BOC Sciences Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. BOC Sciences Product
Table 74. BOC Sciences Recent Development
Table 75. London Drugs Corporation Information
Table 76. London Drugs Description and Major Businesses
Table 77. London Drugs Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. London Drugs Product
Table 79. London Drugs Recent Development
Table 80. Abhilasha Pharma Pvt Ltd Corporation Information
Table 81. Abhilasha Pharma Pvt Ltd Description and Major Businesses
Table 82. Abhilasha Pharma Pvt Ltd Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Abhilasha Pharma Pvt Ltd Product
Table 84. Abhilasha Pharma Pvt Ltd Recent Development
Table 85. Tocris Corporation Information
Table 86. Tocris Description and Major Businesses
Table 87. Tocris Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Tocris Product
Table 89. Tocris Recent Development
Table 90. ChemSpider Corporation Information
Table 91. ChemSpider Description and Major Businesses
Table 92. ChemSpider Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. ChemSpider Product
Table 94. ChemSpider Recent Development
Table 95. Rxlist Corporation Information
Table 96. Rxlist Description and Major Businesses
Table 97. Rxlist Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Rxlist Product
Table 99. Rxlist Recent Development
Table 100. Beijing Taiyang Corporation Information
Table 101. Beijing Taiyang Description and Major Businesses
Table 102. Beijing Taiyang Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Beijing Taiyang Product
Table 104. Beijing Taiyang Recent Development
Table 105. Sigma Aldrich Corporation Information
Table 106. Sigma Aldrich Description and Major Businesses
Table 107. Sigma Aldrich Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sigma Aldrich Product
Table 109. Sigma Aldrich Recent Development
Table 110. Hubei Jusheng Technology Corporation Information
Table 111. Hubei Jusheng Technology Description and Major Businesses
Table 112. Hubei Jusheng Technology Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Hubei Jusheng Technology Product
Table 114. Hubei Jusheng Technology Recent Development
Table 115. Xiamen Hisunny Chemical Corporation Information
Table 116. Xiamen Hisunny Chemical Description and Major Businesses
Table 117. Xiamen Hisunny Chemical Pioglitazone HCL Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Xiamen Hisunny Chemical Product
Table 119. Xiamen Hisunny Chemical Recent Development
Table 120. Cangzhou Senary Chemical Science-tech Corporation Information
Table 121. Cangzhou Senary Chemical Science-tech Description and Major Businesses
Table 122. Cangzhou Senary Chemical Science-tech Pioglitazone HCL Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Cangzhou Senary Chemical Science-tech Product
Table 124. Cangzhou Senary Chemical Science-tech Recent Development
Table 125. SHANDONG JIULONG HISINCE PHARMACEUTICAL Corporation Information
Table 126. SHANDONG JIULONG HISINCE PHARMACEUTICAL Description and Major Businesses
Table 127. SHANDONG JIULONG HISINCE PHARMACEUTICAL Pioglitazone HCL Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. SHANDONG JIULONG HISINCE PHARMACEUTICAL Product
Table 129. SHANDONG JIULONG HISINCE PHARMACEUTICAL Recent Development
Table 130. Hubei YuanCheng SaiChuang Technology Corporation Information
Table 131. Hubei YuanCheng SaiChuang Technology Description and Major Businesses
Table 132. Hubei YuanCheng SaiChuang Technology Pioglitazone HCL Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Hubei YuanCheng SaiChuang Technology Product
Table 134. Hubei YuanCheng SaiChuang Technology Recent Development
Table 135. Global Pioglitazone HCL Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Pioglitazone HCL Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Pioglitazone HCL Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Pioglitazone HCL Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Pioglitazone HCL Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Pioglitazone HCL Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Pioglitazone HCL Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Pioglitazone HCL Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Pioglitazone HCL Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Pioglitazone HCL Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Pioglitazone HCL Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Pioglitazone HCL Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Pioglitazone HCL Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Pioglitazone HCL Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Pioglitazone HCL Players
Table 153. Pioglitazone HCL Customers List
Table 154. Pioglitazone HCL Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Pioglitazone HCL Product Picture
Figure 2. Global Pioglitazone HCL Sales Market Share by Type in 2020 & 2026
Figure 3. 15 mg Product Picture
Figure 4. 30 mg Product Picture
Figure 5. 45 mg Product Picture
Figure 6. Global Pioglitazone HCL Sales Market Share by Application in 2020 & 2026
Figure 7. Industrial
Figure 8. Pharmaceuticals
Figure 9. Other
Figure 10. Pioglitazone HCL Report Years Considered
Figure 11. Global Pioglitazone HCL Market Size 2015-2026 (US$ Million)
Figure 12. Global Pioglitazone HCL Sales 2015-2026 (K MT)
Figure 13. Global Pioglitazone HCL Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pioglitazone HCL Sales Market Share by Region (2015-2020)
Figure 15. Global Pioglitazone HCL Sales Market Share by Region in 2019
Figure 16. Global Pioglitazone HCL Revenue Market Share by Region (2015-2020)
Figure 17. Global Pioglitazone HCL Revenue Market Share by Region in 2019
Figure 18. Global Pioglitazone HCL Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pioglitazone HCL Revenue in 2019
Figure 20. Pioglitazone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pioglitazone HCL Sales Market Share by Type (2015-2020)
Figure 22. Global Pioglitazone HCL Sales Market Share by Type in 2019
Figure 23. Global Pioglitazone HCL Revenue Market Share by Type (2015-2020)
Figure 24. Global Pioglitazone HCL Revenue Market Share by Type in 2019
Figure 25. Global Pioglitazone HCL Market Share by Price Range (2015-2020)
Figure 26. Global Pioglitazone HCL Sales Market Share by Application (2015-2020)
Figure 27. Global Pioglitazone HCL Sales Market Share by Application in 2019
Figure 28. Global Pioglitazone HCL Revenue Market Share by Application (2015-2020)
Figure 29. Global Pioglitazone HCL Revenue Market Share by Application in 2019
Figure 30. North America Pioglitazone HCL Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Pioglitazone HCL Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pioglitazone HCL Sales Market Share by Country in 2019
Figure 33. North America Pioglitazone HCL Revenue Market Share by Country in 2019
Figure 34. U.S. Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pioglitazone HCL Market Share by Type in 2019
Figure 39. North America Pioglitazone HCL Market Share by Application in 2019
Figure 40. Europe Pioglitazone HCL Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Pioglitazone HCL Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pioglitazone HCL Sales Market Share by Country in 2019
Figure 43. Europe Pioglitazone HCL Revenue Market Share by Country in 2019
Figure 44. Germany Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pioglitazone HCL Market Share by Type in 2019
Figure 55. Europe Pioglitazone HCL Market Share by Application in 2019
Figure 56. Asia Pacific Pioglitazone HCL Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Pioglitazone HCL Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pioglitazone HCL Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pioglitazone HCL Revenue Market Share by Region in 2019
Figure 60. China Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pioglitazone HCL Market Share by Type in 2019
Figure 83. Asia Pacific Pioglitazone HCL Market Share by Application in 2019
Figure 84. Latin America Pioglitazone HCL Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Pioglitazone HCL Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pioglitazone HCL Sales Market Share by Country in 2019
Figure 87. Latin America Pioglitazone HCL Revenue Market Share by Country in 2019
Figure 88. Mexico Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pioglitazone HCL Market Share by Type in 2019
Figure 95. Latin America Pioglitazone HCL Market Share by Application in 2019
Figure 96. Middle East and Africa Pioglitazone HCL Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Pioglitazone HCL Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pioglitazone HCL Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pioglitazone HCL Revenue Market Share by Country in 2019
Figure 100. Turkey Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Pioglitazone HCL Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Pioglitazone HCL Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Pioglitazone HCL Market Share by Type in 2019
Figure 107. Middle East and Africa Pioglitazone HCL Market Share by Application in 2019
Figure 108. North America Pioglitazone HCL Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Pioglitazone HCL Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Pioglitazone HCL Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Pioglitazone HCL Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Pioglitazone HCL Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Pioglitazone HCL Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Pioglitazone HCL Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Pioglitazone HCL Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Pioglitazone HCL Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Pioglitazone HCL Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
非アルコール性脂肪性肝炎（NASH）治療薬の世界市場（～2026年） Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…- 向精神薬の世界市場（～2026年） Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior. The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of…
- 特殊医薬品の世界市場（～2026年） Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs. North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this mar…
- 医薬品の世界市場（～2026年） The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable. North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry…
- 病院製剤の世界市場（～2026年） With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector. Market Analysis and Insights: Global Hospital Pharmaceuticals Market The global Hospital Pharmaceuticals market size is project…